No Data
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
Resmed Stock Sees Alarming Drop Alongside a New Obstructive Sleep Apnea Treatment Rival
Express News | Resmed Shares Down 4% and Inspire Medical Systems Shares Fall 2.7% in Early Trading
Express News | Resmed Shares Down 5.2% Premarket After U.S. FDA Approves Lilly's Weight-Loss Drug for Sleep Apnea
Possible Bearish Signals With ResMed Insiders Disposing Stock
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}